期刊
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS
卷 7, 期 5, 页码 434-442出版社
SPRINGER
DOI: 10.1007/s11910-007-0067-6
关键词
-
资金
- NATIONAL INSTITUTE ON AGING [R01AG026251, P01AG017216, P50AG016574] Funding Source: NIH RePORTER
- NIA NIH HHS [R01 AG026251, P50 AG16574, P01 AG017216] Funding Source: Medline
The clinical disorders associated with frontotemporal lobar degeneration (FTLD) are increasingly recognized as an important cause of early-onset dementia. Patients usually present with progressive changes in personality, behavior, or language, progressing to general cognitive impairment and ultimately death. In the past decade, improved clinical and histopathologic characterization uncovered extensive heterogeneity, and multiple clinical and pathologic FTLD subtypes were defined. Simultaneously, the discovery of four causal FTLD genes emphasized the genetic complexity associated with FTLD. More recently, the field of FTLD has gained increased attention as a result of two major findings. First, mutations in the progranulin gene (PGRN) were recognized as a major cause of FTLD with ubiquitin-positive and tau-negative inclusions (FTLD-U), and subsequently the TAR DNA-binding protein-43 (TDP-43) was identified as a key protein within the ubiquitinated inclusions in FTLD-U and amyotrophic lateral sclerosis (ALS). In this report, we outline the progress made in the study of the genetic etiologies and neuropathologic substrates in FTLD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据